![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 1
Zeitschriftenartikel
Wirawan, Ricky 
ORCID: https://orcid.org/0009-0003-6877-3704; Frei, Matthias ORCID: https://orcid.org/0009-0006-4364-0931; Heider, Anna ORCID: https://orcid.org/0009-0004-0285-607X; Papenkordt, Niklas ORCID: https://orcid.org/0000-0003-3420-0695; Friedrich, Florian ORCID: https://orcid.org/0000-0001-5420-6184; Wein, Thomas ORCID: https://orcid.org/0009-0007-0256-7341; Jung, Manfred ORCID: https://orcid.org/0000-0002-6361-7716; Groll, Michael ORCID: https://orcid.org/0000-0002-1660-340X; Huber, Eva M. ORCID: https://orcid.org/0000-0001-8018-7204 und Bracher, Franz ORCID: https://orcid.org/0000-0003-0009-8629
(2025):
Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD+ co-factor binding.
In: RSC Medicinal Chemistry [Forthcoming]
ORCID: https://orcid.org/0009-0003-6877-3704; Frei, Matthias ORCID: https://orcid.org/0009-0006-4364-0931; Heider, Anna ORCID: https://orcid.org/0009-0004-0285-607X; Papenkordt, Niklas ORCID: https://orcid.org/0000-0003-3420-0695; Friedrich, Florian ORCID: https://orcid.org/0000-0001-5420-6184; Wein, Thomas ORCID: https://orcid.org/0009-0007-0256-7341; Jung, Manfred ORCID: https://orcid.org/0000-0002-6361-7716; Groll, Michael ORCID: https://orcid.org/0000-0002-1660-340X; Huber, Eva M. ORCID: https://orcid.org/0000-0001-8018-7204 und Bracher, Franz ORCID: https://orcid.org/0000-0003-0009-8629
(2025):
Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD+ co-factor binding.
In: RSC Medicinal Chemistry [Forthcoming]